Nusamed delivers sophisticated medical equipment, pharmaceuticals and in-vitro diagnostics — including ADPS technology — to healthcare providers, institutions and rural communities across Indonesia.
Your trusted partner in Indonesia's healthcare supply landscape. Established in 2019, Nusamed emerged on the cusp of the global COVID-19 crisis with a mission to revolutionize healthcare access and in vitro diagnostics. Our unwavering commitment is to empower healthcare providers, institutions, and individuals with a comprehensive range of sophisticated medical equipment, pharmaceuticals, and in vitro diagnostic solutions. At Nusamed, we prioritize enhancing access to essential health services, particularly for rural communities, ensuring timely medical check-ups and accurate diagnostics. Our portfolio is meticulously curated to meet the evolving demands of contemporary healthcare, leveraging cutting-edge technologies like ADPS to offer high-quality solutions. Our strong relationships with government entities and a diverse network of stakeholders amplify our credibility, allowing us to collaborate on impactful initiatives.
To be the leading healthcare solutions provider in Indonesia, driving innovation and accessibility in medical diagnostics and healthcare supplies, ensuring that every individual, regardless of location, has access to world-class healthcare.
To offer high-quality medical equipment, pharmaceuticals, and in vitro diagnostics that enable healthcare professionals to deliver better, more accurate care everytime and everywhere.
To leverage cutting-edge technologies like ADPS to provide advanced healthcare solutions that adapt to the evolving needs of the healthcare sector.
To improve access to essential healthcare services, particularly in underserved rural areas, ensuring timely check-ups and accurate diagnostics for all.
A focused portfolio led by our flagship ADPS Cancer Test Kit, alongside a growing range of test kits for community and clinical use.
Powered by ADPS™ Smart DNA Polymerase II — a high-sensitivity Taq polymerase specifically engineered for AS-PCR. Distinct mismatch-discrimination at the 3' end of primers enables ultra-sensitive detection of rare cancer-associated mutations, SNP genotyping and genetic disease testing.
Supporting healthcare with trusted medical supplies and diagnostics.
Providing sophisticated tools to enhance patient care across Indonesia.
Reliable medicines ensuring timely treatment for communities everywhere.
Accurate diagnostic solutions tailored for remote and rural healthcare needs.
A founding team and board grounded in healthcare, logistics, technology and public-sector experience — closing the access gap one shipment at a time.
As CEO of Nusamed, Nuniek brings over 20 years of expertise in supply chain management, specializing in service parts logistics and pharmace...
Sharfina, co-founder and Head of Commercial at Nusamed, leverages her extensive background in growth, strategy, and operations from the fast...
Wahyuddin brings extensive leadership experience as Nusamed's commissioner. He served 10 years as President Director of a state-owned electr...
Prof. Abdul Kadir is the commissioner of Nusamed, bringing extensive expertise in healthcare management and leadership. His career includes...
From Sumatra to Papua, from a 4-bed clinic to a 1,000-bed hospital — the same standards, the same care, the same Nusamed team behind every order.
Our team responds to procurement and partnership enquiries within one business day.
